Fast-acting treatment of myasthenic crisis with efgartigimod from the perspective of the neonatal intensive care unit

Fast-acting treatment of myasthenic crisis with efgartigimod from the perspective of the neonatal intensive care unit

Abstract Background Myasthenic crisis (MC) refers to rapid deterioration of myasthenia gravis (MG), affecting lung and bulbar muscles and causing breathing difficulties. Currently, efgartigimod has shown good therapeutic effects in patients with generalized myasthenia gravis (GMG). This retrospectiv...

Full description

Bibliographic Details
Main Authors: Fangyi Shi, Rong Lai, Li Feng, Hongyan Zhou, Xunsha Sun, Cunzhou Shen, Jiezhen Feng, Zhilong Xu, Haiyan Wang, Huiyu Feng
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Neurology
Subjects:
Myasthenic crisis
Myasthenia gravis
Efgartigimod
Fast-acting treatment
The neonatal intensive care unit
Online Access:https://doi.org/10.1186/s12883-025-04063-1

Internet

https://doi.org/10.1186/s12883-025-04063-1

Similar Items